Adaptimmune Therapeutics (ADAP) News Today $0.28 +0.01 (+4.62%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$0.27 -0.01 (-2.85%) As of 07/14/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADAP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Adaptimmune Therapeutics PLC ADR - Barron'sJuly 11, 2025 | barrons.comAdaptimmune Therapeutics (NASDAQ:ADAP) Share Price Crosses Below 50-Day Moving Average - What's Next?July 8, 2025 | marketbeat.comAdaptimmune Therapeutics PLC (NASDAQ:ADAP) Given Consensus Recommendation of "Hold" by AnalystsJune 29, 2025 | marketbeat.comMizuho Downgrades Adaptimmune Therapeutics plc - Depositary Receipt () (ADAP)June 27, 2025 | msn.comMizuho downgrades Adaptimmune stock on solvency concernsJune 26, 2025 | investing.comAdaptimmune Therapeutics (NASDAQ:ADAP) Downgraded to "Neutral" Rating by MizuhoJune 26, 2025 | marketbeat.comAdaptimmune Therapeutics (NASDAQ:ADAP) Stock Price Crosses Below 50-Day Moving Average - Here's What HappenedJune 26, 2025 | marketbeat.comAdaptimmune Therapeutics (NASDAQ:ADAP) Stock Price Passes Below 50-Day Moving Average - Here's What HappenedJune 18, 2025 | marketbeat.comBank of America Corp DE Has $1.54 Million Stock Position in Adaptimmune Therapeutics plc (NASDAQ:ADAP)June 5, 2025 | marketbeat.comAdaptimmune Therapeutics PLC: Adaptimmune to Report Full Year and Q4 2024 Financial and Business Updates on Thursday, March 20, 2025June 4, 2025 | finanznachrichten.deAdaptimmune Therapeutics plc (NASDAQ:ADAP) Given Average Recommendation of "Hold" by BrokeragesJune 4, 2025 | marketbeat.comShort Interest in Adaptimmune Therapeutics plc (NASDAQ:ADAP) Expands By 31.0%June 2, 2025 | marketbeat.comTwo Seas Capital LP Invests $7.99 Million in Adaptimmune Therapeutics plc (NASDAQ:ADAP)May 23, 2025 | marketbeat.comAdaptimmune Therapeutics (NASDAQ:ADAP) Earns Buy Rating from Analysts at StockNews.comMay 18, 2025 | marketbeat.comAdaptimmune Therapeutics (NASDAQ:ADAP) Issues Earnings Results, Misses Expectations By $0.01 EPSMay 15, 2025 | marketbeat.comAdaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2025 Earnings Call TranscriptMay 14, 2025 | insidermonkey.comAdaptimmune Therapeutics PLC (ADAP) Q1 2025 Earnings Call Highlights: Strong Tecelra Launch ...May 14, 2025 | finance.yahoo.comAdaptimmune Therapeutics plc (ADAP) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comA Look Ahead: Adaptimmune Therapeutics's Earnings ForecastMay 12, 2025 | benzinga.comAdaptimmune Q1 2025 Earnings PreviewMay 12, 2025 | msn.comAdaptimmune Therapeutics plc (NASDAQ:ADAP) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 12, 2025 | marketbeat.comAdaptimmune Therapeutics (ADAP) to Release Earnings on TuesdayMay 11, 2025 | marketbeat.comAdaptimmune Therapeutics plc (NASDAQ:ADAP) Short Interest Down 15.8% in AprilMay 5, 2025 | marketbeat.comAnalysts Conflicted on These Healthcare Names: QuidelOrtho (QDEL) and Enliven Therapeutics (ELVN)May 2, 2025 | theglobeandmail.comTwo Seas Capital LP Takes $7.99 Million Position in Adaptimmune Therapeutics plc (NASDAQ:ADAP)April 27, 2025 | marketbeat.comLong Focus Capital Management LLC Increases Stock Position in Adaptimmune Therapeutics plc (NASDAQ:ADAP)April 25, 2025 | marketbeat.comAdaptimmune Therapeutics (NASDAQ:ADAP) Coverage Initiated at StockNews.comApril 23, 2025 | marketbeat.comAdaptimmune Therapeutics plc (NASDAQ:ADAP) Given Average Rating of "Moderate Buy" by BrokeragesApril 17, 2025 | marketbeat.comAdaptimmune Therapeutics (NASDAQ:ADAP) Now Covered by Analysts at StockNews.comApril 15, 2025 | marketbeat.comAdaptimmune downgraded to Hold from Buy at JonesResearchApril 11, 2025 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Receipts Fall in Thursday TradingApril 3, 2025 | msn.comWhat Analysts Are Saying About Adaptimmune Therapeutics StockApril 3, 2025 | nasdaq.comHC Wainwright Has Lowered Expectations for Adaptimmune Therapeutics (NASDAQ:ADAP) Stock PriceApril 2, 2025 | marketbeat.comAdaptimmune price target lowered to $3 from $3.50 at H.C. WainwrightApril 1, 2025 | markets.businessinsider.com4ADAP : What Analysts Are Saying About Adaptimmune Therapeutics...April 1, 2025 | benzinga.comAdaptimmune Therapeutics (NASDAQ:ADAP) Now Covered by StockNews.comMarch 30, 2025 | marketbeat.comAnalysts Set Expectations for ADAP Q1 EarningsMarch 29, 2025 | marketbeat.comBarclays Remains a Sell on Adaptimmune Therapeutics (ADAP)March 28, 2025 | markets.businessinsider.comQ1 Earnings Estimate for ADAP Issued By Zacks Small CapMarch 28, 2025 | marketbeat.comAdaptimmune Therapeutics (NASDAQ:ADAP) Given New $1.75 Price Target at GuggenheimMarch 27, 2025 | marketbeat.comAdaptimmune price target lowered to $1.75 from $3 at GuggenheimMarch 27, 2025 | markets.businessinsider.comAdaptimmune Therapeutics Amends Loan AgreementMarch 26, 2025 | investing.comAdaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2024 Earnings Call TranscriptMarch 26, 2025 | insidermonkey.comAdaptimmune Therapeutics (ADAP) Gets a Buy from ScotiabankMarch 25, 2025 | markets.businessinsider.comAdaptimmune Therapeutics (NASDAQ:ADAP) Releases Quarterly Earnings Results, Misses Estimates By $0.09 EPSMarch 25, 2025 | marketbeat.comAdaptimmune Therapeutics plc (NASDAQ:ADAP) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarch 22, 2025 | marketbeat.comWells Fargo & Company Cuts Adaptimmune Therapeutics (NASDAQ:ADAP) Price Target to $1.50March 22, 2025 | marketbeat.comAdaptimmune Therapeutics (NASDAQ:ADAP) Price Target Lowered to $1.40 at ScotiabankMarch 22, 2025 | marketbeat.comEarnings call transcript: Adaptimmune Q4 2024 targets $25M sales in 2025March 22, 2025 | uk.investing.comAdaptimmune Therapeutics plc (ADAP) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | seekingalpha.com Get Adaptimmune Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAP and its competitors with MarketBeat's FREE daily newsletter. Email Address ADAP Media Mentions By Week ADAP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADAP News Sentiment▼0.870.98▲Average Medical News Sentiment ADAP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADAP Articles This Week▼32▲ADAP Articles Average Week Get Adaptimmune Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TNXP News ALLO News INZY News ALDX News CADL News ACB News SGMT News IMMP News CRDF News FENC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADAP) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptimmune Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADAP Stock Alerts